Integrated Analysis Reveals COL4A3 as a Novel Diagnostic and Therapeutic Target in UV-Related Skin Cutaneous Melanoma.

Zuochao YaoLu Lu Qian-Hui XuShan HuaHui WangHua Jiang

Published in: Clinical, cosmetic and investigational dermatology (2024)

The efficacy of the prognostic model was validated by analyzing the prognosis, immune infiltration, and immune checkpoint profiles. COL4A3 stands out as a novel diagnostic and therapeutic target for SKCM, offering new strategies for small-molecule targeted drug therapies.

Keyphrases

small molecule
cancer therapy
protein protein
soft tissue
emergency department
drug induced
wound healing
adverse drug
skin cancer